CN Stock MarketDetailed Quotes

300601 Shenzhen Kangtai Biological Products

Watchlist
  • 16.73
  • -0.37-2.16%
Market Closed Jun 14 15:00 CST
18.69BMarket Cap26.31P/E (TTM)

About Shenzhen Kangtai Biological Products Company

The company was founded in 1992 and listed on the Shenzhen Stock Exchange GEM in February 2017. It is the first listed vaccine company in South China. It has developed into a high-tech enterprise with complete R&D varieties, rich product lines, and obvious technical advantages. It has R&D and production capabilities for viral vaccines, bacterial vaccines, genetically engineered vaccines, conjugated vaccines, and multivalent multivalent vaccines. The company's main business is research and development, production and sales of human vaccines. Major products include recombinant hepatitis B vaccine (10ug, 20ug, 60ug), 23-valent pneumococcal polysaccharide vaccine, acellular haemophilus influenzae type b combination vaccine, 13-valent pneumococcal conjugate vaccine, and freeze-dried human rabies vaccine (human diploid cells). The company has received honors such as Guangdong Innovative Enterprise, Guangdong High-tech Product Certificate, National Torch Program Key High-tech Enterprise Certificate, Guangdong Youth Leading Enterprise, and Shenzhen Science and Technology Progress Award.

Company Profile

Short Name-A康泰生物
Symbol-A300601
Company NameShenzhen Kangtai Biological Products Co.,Ltd.
Listing DateFeb 7, 2017
Issue Price3.29
Shares Offered42.00M share(s)
FoundedSep 8, 1992
Legal Representativeweimin du
General Managerxiang miao
Secretaryjin tao
Accounting FirmShinnaganaka & Chung Certified Public Accountants (Special General Partnership)
Securities Representativejin tao
Legal CounselGuo Hao Law Firm (Shenzhen)
Employees609
Phone0755-26988558
Office AddressKangtai Group Building, No. 222 Kefa Road, Science Park Community, Yuehai Street, Nanshan District, Shenzhen
Zip Code518057
Registered Address101 Kangtai Group Building, No. 222 Kefa Road, Science Park Community, Yuehai Street, Nanshan District, Shenzhen
Fax0755-26988600
Emailoffice@biokangtai.com
Business License440301103121741
BusinessDevelopment, production and operation of hepatitis B vaccine and other medical biological products; import and export business (specifically according to qualification certificates); investment in pharmaceutical projects and other industries (specific projects to be declared separately); pharmaceutical technology development, information consulting services, own housing, equipment leasing services (excluding restricted projects); general freight; special cargo transportation (refrigeration and preservation); non-residential real estate leasing; property management; conference and exhibition services.

Company Executives

  • Name
  • Position
  • Salary
  • weimin du
  • Chairman,directors
  • 3.51M
  • feidong wen
  • Vice Chairman,directors
  • 2.11M
  • jiankai liu
  • directors,VP
  • 3.58M
  • xiang miao
  • directors,President,Member of the Remuneration and Assessment Committee
  • 3.50M
  • jiaoyu li
  • Independent directors
  • 150.00K
  • zhiquan luo
  • Independent directors
  • 150.00K
  • keping hu
  • Independent directors
  • 150.00K
  • jin tao
  • Board Secretary,Securities affairs representative
  • 1.15M
  • zhiyun lv
  • Chairman of the Supervisory Board,Shareholder Supervisors
  • 60.00K
  • hui zhou
  • Chief Financial Officer
  • 1.37M
  • aiping yin
  • Employee supervisors
  • 212.90K
  • zaode cai
  • Employee supervisors
  • 341.70K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg